ABC Lateline: An Interview With Liz Parrish
/
Jeremy Fernandez speaks to Liz Parrish, the CEO of BioViva - an American biotech developing treatments to slow the ageing process in humans.
Becoming the First Transhuman: A Call For The Right Stuff
/
Who will officially be the first transhuman?
Can this woman cure ageing with gene therapy?
/Elizabeth Parrish is CEO of BioViva, a Seattle-based biotech company working to develop treatments to slow the ageing process. In April, the company revealed that Parrish herself had undergone “the first gene therapy successful against human ageing”. The treatment, it claimed, had reversed the biological age of her immune cells by 20 years.
Did A Biotech CEO Reverse Her Own Aging Process?
/
According to BioViva and to interviews with its CEO, Elizabeth Parrish, Parrish received two therapies last year, one to protect against the loss of muscle mass, and one to lengthen her telomeres.
Gene doping in sport could make the Olympics fairer and safer
/
Elizabeth Parrish of the anti-ageing company BioViva claims to have given herself two kinds of experimental gene therapy, one of which blocks the breakdown of muscle tissue. In other words, your muscles stay strong even if you don’t exercise – and grow faster if you do.
Liz Parrish Is Patient Zero in Her Own Anti-Aging Experiment
/
Elizabeth (Liz) Parrish is the CEO of BioViva, a biotechnology company that focuses on developing gene therapies, and other regenerative therapies, to intervene with human aging.Last September, Parrish added an interesting line to her job description: patient zero for two anti-aging therapies that the company is researching.
First Data from Anti-Aging Gene Therapy
/
A biotech company reports that an experimental treatment elongated its CEO’s telomeres.
Scientists Claim They've Completed the First Successful Gene Therapy Against Human Ageing
/
The CEO of Bioviva USA Inc, Elizabeth Parrish, claims to be the first human in world history to have successfully reversed the effects of natural ageing - thanks to experimental gene therapy provided by her company.
Scientists Say They’ve Completed the First Ever Successful Gene Therapy to Combat Old Age
/
Elizabeth Parrish, the CEO of BioViva USA Inc, a biotechnology company that “aims to provide regenerative medicine to the masses through gene and cell therapies,” claims to be the first person in history to have successfully reversed one of the hallmark signs of aging with the company’s experimental gene therapy.
Is Silicon Valley Birthing The Next Pro-Lifers?
/
Elizabeth Parrish is 44, the tough-gunning, sharp-talking CEO of a life-sciences startup, and seemingly full of life herself. But she says she suffers from a deadly disease. Hoping to stave off the sickness, Parrish recently journeyed to a clinic in Colombia, where she underwent a course of therapy that the FDA hasn’t touched with a 10-foot pole. One treatment would alter her telomeres — the stuff at the end of her DNA. The other would inhibit a protein that stops muscle growth.
A Tale of Do-It-Yourself Gene Therapy
/Can aging be slowed by using gene therapy to make permanent changes to a person’s DNA?
Read MoreAnti-aging Gene Therapy: Has The Time Arrived For True Anti-aging Medicine?
/
Now in 2016 it is becoming increasingly clear that therapies are emerging which could seriously impact aspects of the human aging process.
One of the most cutting-edge therapies that are now being tested is the use of viral vectors to lengthen telomeres, the DNA caps at the end of our chromosomes. Elizabeth Parrish, CEO of the company Bioviva USA inc, is the first person to treat human aging with this technology, using herself as a test subject.
Contrary to much buzz within the anti-aging field, this is certainly a valid treatment for a part of the aging problem in organisms, by preventing DNA from shortening. Back in 2012 this experiment was first set up in mice by Maria Blasco et al, using adeno viruses to lengthen telomeres in mice. The treated mice lived longer on average with no increased cancer rates, showing proof of principle.
Read MoreHuman Gene Therapy Successfully Lengthens Telomeres
/
In a bold and courageous move Elizabeth Parrish, CEO of Bioviva USA inc. became the first human to be treated with two gene therapies that her company has developed, one to lengthen her telomeres and one to prevent aging-related loss in muscle mass. With this move, she follows the footsteps of other courageous scientists, such as […]
Read MorePromising Results From The First Human Gene Therapy Against Aging
/
The CEO of Bioviva USA Inc., Elizabeth Parrish, became the first person to undergo rejuvenative gene therapy in 2015, and results are now out – the procedure successfully lengthened her telomeres by the equivalent of 20 years.
Read MoreFirst Gene Therapy Successful Against Human Aging
/
In September 2015, then 44 year-old CEO of BioViva USA Inc. Elizabeth Parrish received two of her own company’s experimental gene therapies: one to protect against loss of muscle mass with age, another to battle stem cell depletion responsible for diverse age-related diseases and infirmities.
The treatment was originally intended to demonstrate the safety of the latest generation of the therapies. But if early data is accurate, it is already the world’s first successful example of telomere lengthening via gene therapy in a human individual. Gene therapy has been used to lengthen telomeres before in cultured cells and in mice, but never in a human patient.
Read More
Seattle WA
facebook
twitter
instagram
linkedin
youtube